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THE LANCET, NOVEMBER 23, 1974 
vou ask in your editorial-forms the kernel of the argument 
for both interdisciplinary students and interdisciplinary 
staff in the teaching of community health. In my opinion, 
a health professional is a person whose work has some effect 
on the health of the community, either directly. or indirectly 
(i.e., economists, school teachers, veterinarians, and so on), 
and who undertakes further training in the health-related 
aspects of his work. All such people, if suitably qualified, 
would be welcome on the M.COMM.H. course. 
Department of Tropical Community 
Health, 
Liverpool School of Tropical Medicine, 
Pembroke Place, Liverpool L3 5QA. FRANCIS M. SHATTOCK. 
EPIDEMIOLOGY OF CROHN'S DISEASE 
SIR,-Dr Barker and Dr Gardner (Nov. 9, p. 1140) 
were right to draw attention to the regional variation in 
discharge-rates for Crohn's disease and ulcerative colitis in 
England and Wales. We decided to use national rather than 
regional data to compare with our own and that from the 
specified countries in Northern Europe, where prevalence 
of the disease is comparable with our own figure. Con-
siderable caution is necessary in interpreting regional data 
because it is not collected with the same care as that given 
to special studies. 
Departments of Community Health 
and Therapeutics, 
Medical School, 
Nottingham University, 
University Park, 
Nottingham NG7 2RD. 
D. S. MILLER 
A. C. KEIGHLEY 
M. J. S. LANGMAN. 
PORTACAVAL SHUNT IN HYPERLIPIDlEMIA 
Sm,-Twice previously in this journal we described 
amelioration of symptoms in an ll-year-old girl with 
homozygous rype-I1a hyperlipoproteina:mia following 
end-to-side portacaval shunt. 1,' Preoperatively, the child 
had suffered severe myocardial infarction. After operation, 
serum cholesterol and low-density-lipoprotein concentra-
tions were reduced. Cutaneous and tendinous xanthomas 
underwent resorption. There was apparent regression of 
cardiovascular disease with relief of angina and reversal of 
ao~c stenosis. However, coronary angiograms 16 months 
after portacaval shunt showed three residual tight stenoses: 
one at the bifurcation of the left coronary artery into the 
circumflex and left anterior descending arteries; a second 
more distal in the circumflex artery; and the third in the 
right coronary artery. A coronary bypass procedure was 
decided against because of the belief that these lesions 
might resolve spontaneously. 
The patient was last seen by us on Sept. 14, 1974, as the 
subject of a Grand Rounds at the University. She felt well 
and had normal liver-function tests. On Sept. 23, while 
~~g home from school, she collapsed in the street and 
died Immediately. At necropsy, 18t months after portacaval 
shunt, the most important findings were in the cardio-
~ascular system. The heart was greatly enlarged, weighing 
10 g. (normal 200 g.). There was a large left ventricular 
~eurysm which was the result of the . old myocardial 
~nfarcti?nK The three coronary-artery stenoses identified J angIography 3 months earlier were still present but nre we.re no thromboses or areas of fresh infarction. 
art e .aomc valve easily admitted the tip of a finger. Many 
d enc:s, as well as the aorta, had residual xanthomatous r:lplt~K The right and left lungs weighed 415 and 340 g., 
pectlvely, and had histological features consistent with 
---
lKp~~q------------------------------------
1973 .: b~I Chase, H. P., Putnam, C. W., Poner, K. A. Lancet, 
2 S ' ll, 940. 
• ~41I T. E., Chase, H. P., Putnam, C. W., Nora,].J. ibid. Sept. 21, 
, p. 714. 
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the chronic right-heart failure from which she had suffered 
since the original myocardial infarction. 
The liver, which weighed 618 g., was grossly normal, and 
microscopically it was unchanged from the biopsy obtained 
6 months postoperatively. 1 The portacaval shunt was widely 
patent. From the clinical course and the necropsy findings, 
the conclusions of the clinicians and pathologists was that 
death was by an acute cardiac arrhythmia related to the 
residual coronary-artery disease and/or the earlier myo-
cardial infarction. 
Departments of Surgery, Pediatrics, 
and Pathology, 
University of Colorado Medical 
. Center and 
Veterans Administration Hospital, 
Denver, Colorado 80220, U.S.A., 
and Department of Pathology, 
St. Mary's Hospital and Medical 
School, London W2 1NY. England. 
THOMAS E. STARZL 
H. PETER CHASE 
CHARLES W. PUTNAM 
JAMES J. NORA 
ROBERT H. FENNELL, JR. 
KENDRICK A. PORTER. 
PORTACAVAL SHUNT IN FAMIUAL 
HYPERCHOLESTEROLffiMIA 
SIR,-The reports 1.2 by Dr Thomas Starzl and his 
colleagues of the successful use in one patient with homo-
zygous familial hypercholesterolremia of an end-to-side 
portacaval shunt has engendered much discussion. The 
effects of the procedure, and the needs and opportunities 
for further clinical research that it suggests~ were lately 
commented on in a paper and an editorial. 3 ,-
We should like to report briefly on a workshop on this 
subject held at the National Heart and Lung Institute, 
Bethesda, Maryland, on Aug. 1 and 2, 1974. The work-
shop was prompted by the implic;.ations the initial observa-
tion has both for therapy and for the better understanding of 
lipid metabolism and atherogenesis. The small group of 
discussants considered the definition and natural history, 
the pathophysiology of hypercholesterolremia, treatment by 
various means, and the portacaval shunt. Some recom-
mendations on the applicability of the shunt for homo-
zygous familial hypercholesterolremia and for research needs 
arose from this discussion * : 
Conclusions and Recommendations 
(a) The diagnostic criteria for homozygous familial hyper-
cholesterola:mia include serum-cholesterol levels in excess of 
500 mg. per 100 mi., hypercholesterola:mia in both parents, or, in 
the absence of a parent, in both family lines; and the appearance 
of xanthomas in the first decade of life. While these diagnostic 
criteria may be expanded and usefully include tissue-culture 
criteria, the above descriptors constitute a minimum character-
isation for this diagnosis. 
(b) This inborn error of metabolism so limits life expectancy 
that it justifies prompt and intensive treatment. including inno-
vative measures. 
(cl The medical treatment of choice is a combined regimen of a 
low-fat, low-cholesterol diet with a high PIS fatty-acid ratio; a 
bile-acid sequestrant such as cholestyramine (up to 32 g. per day); 
and nicotinic acid (up to 3·0 g. per day) to the limits of tolerance, 
but monitored to avoid abnormally high serum-transaminase 
levels. Successful medical management includes both a major 
(40% or more) and fairly prompt reduction in serum-cholesterol 
and the slower resolution of xanthomas. It is unproven at present 
whether these attributes of management are also accompanied by a 
regression of atherosclerotic vascular disease and a significant 
prolongation of life. Medical management may have little or no 
effect on some patients. 
Cd) The portacaval shunt is an innovation for homozygous 
* A more complete summary of the workshop, including a selected 
bibliography, is available on request from the Atherogenesis 
Branch, Division of Heart and Vascular Diseases, National Heart 
and Lung Institute, Bethesda, Maryland 20014, U.S.A. 
I. Starzl, T. E., Chase, H. P., Putnam, C. W., Poner, K. A. Lancet, 
1973, ii, 940. 
2. Starz!, T. E., Chase, H. P., Putnam, C. W., Nora, J. J. ibid. Sept. 21, 
1974, p. 714 • 
3. Ahrens, E. H., Jr. ibid. Aug. 24, 1974, p. 449. 
4. ibid. p. 444. 
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familial hypercholesterolremia that deserves intensive evaluation 
and study. It is recommended that, for the present, its use should 
be restricted to the patient with severe homozygous familial 
hypercholesterolremia who has clinical vascular disease and who 
fails to respond to intensive medical therapy. 
(e) The procedure should be carried out in institutions with the 
necessary diagnostic, surgical, and investigative metabolic 
expenise to assure, as far as possible, a successful clinical outcome, 
an adequate medical and neuropsychiatric follow-up, and the 
capability to study important metabolic parameters. Intercentre 
cooperation will be helpful. Collaboration with reference 
laboratories that have specialised in the conduct of certain 
specific but uncommon tests is recommended, both in order to 
facilitate the performance of the tests and to standardise their 
quality. 
(f) The development of a central patient registry is recom-
mended to facilitate the prompt collection of information about 
both medical and surgical managements of homozygous familial 
hypercholesterolremia, and to act as a responsive resource for 
investigators and others interested in this problem. 
Not only is homozygous familial hyperchoiesterolremia a 
rare disorder, but there are relatively few medical centres 
in the world capable of the sophisticated sterol, lipoprotein, 
and other studies that may advance our knowledge. Indeed, 
intercentre collaboration may be needed if some investiga-
tions are to be performed economically and in the most 
appropriate way. 
In these circumstances it is advisable to facilitate scientific 
communication, to pool ideas and data, to make the most 
of such data as may be obtained, and to enhance the contri-
bution of future investigations. 
To this end the National Heart and Lung Institute has 
offered to act as an initial focus or registry for information 
exchange on' current or planned shunt procedures for this 
condition. Investigators active in this area are urged to 
communicate with S. M. at the Institute. 
Division of Heart and Vascular 
Disease, 
National Heart and Lung Institute, 
National Institutes of Health, 
Landow Building, Room C.S08, 
Bethesda, Maryland 20014, U.S.A. 
SHIELA MITCHELL 
ROBERT 1. LEVY. 
THE VULNERABLE MYOCARDIUM 
SIR,-As you have rightly pointed out in your editorial 
(Oct. 26, p. 994) too little serious attention has been given 
to those proposing " unconventional " hypotheses for our 
modern epidemics of myocardial infarction, diabetes, &c. 
Anyone reading Cleave's latest work 1 must be struck by 
the strength of his arguments. Trowell 2 has added fuel 
to this fire with his survey of diabetes death-rates and their 
relation to diet. 
In addition to the epidemiological evidence advanced 
by Cleave and others, Anderson 3 postulated an attractive 
biochemical hypothesis related to a myocardium left 
vulnerable to insult because, through a lack of dietary 
antioxidants, the myocardial metabolic machinery is 
incapable of withstanding the dystrophic effect of per-
oxides. He finds that the modern diet has been: (1) stripped 
of d-a-tocopherol; and (2) supplemented with polyun-
saturated fatty acids. Using this sort of approach, one could 
go directly to a myocardial infarction without necessarily 
having atherosclerosis. Support for such a hypothesis 
comes from Richardson et a!.' who have found angina 
pectoris in patients with normal coronary arteries. 
We have grown to accept the view that atherosclerosis 
causes myocardial infarction, the pendulum having swung 
so far that many Governments are now officially in favour 
of increased polyunsaturates. In view of this counter 
1. Cleave, T. L. The Saccharine Disease. Bristol, ~ 974. 
.... Trowell, H. Lancet, 1974, Ii, p. 998. 
3 .• 'Uloerson, T. Wf. ,hid. 1973, ii, 298. 
.1, Richardson. P. J.} Livesley, B., Oram, S., Olsen, E. G. J., Armstrong, 
~FK loid. :'974. ii. :]T!. 
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hypothesis, such action could potentially exacerbate the 
problem. 
Royal College of Surgeons in 
Ireland, 
St. pteph~nDs Green, 
Dublin. CHRISTOPHER HASSELL. 
ISCHlEMIC HEART -DISEASE AND DIET 
SIR,-Your leader (Aug. 24, p. 444) on portacaval 
anastomosis for metabolic disease drew attention to the 
remarka ble case of a child reported by S tarzl et aJ.1·2 with 
xanthomas, myocardial infarction, and serum-cholesterol 
level of 900 mg. per 100 ml. (32·2 mmole per 1.). Diet and 
drugs were ineffective, but intravenous feeding halved the 
serum-cholesterol for a few weeks. Portacaval anastomosis 
was followed by a fall to 240 mg. per 100 ml. (6'3 mmole 
per 1.), resolution of xanthomas, and relief of angina. 
The endoplasmic reticulum of the liver cells was reduced 
after operation, suggesting that cholesterol production may 
have decreased. 
An enzyme system responding by an increase when 
exposed to high concentrations of substrates would fit 
the observations, the high concentrations of digestion 
products reaching the liver after each meal being reduced 
by intravenous feeding or portacaval shunt. 
The implications of this theory are: (1) intragastric drip 
feed should be as effective as intravenous .. feeding"; 
numerous small feeds spread over the day may lower the 
serum-lipids without a change in total intake; (2) the 
restriction of cholesterol, saturated fats, and simple sugars 
may owe some of their failure to the custom of one large 
meal per day. 
The Guest Hospital, 
Dudley DYl 4SE. E. BOWERS. 
EPSILON-AMINO CAPROIC ACID 
SIR,-We were very pleased to learn. that Mr Uttley 
and Mr Richardson (Nov. 2, p. 1080) have not seen serious 
complications resulting from the administration of anti-
fibrinolytic drugs in a large series of patients with sub-
arachnoid hremorrhage. 
We would, however, wish to question their assertion that 
the re-bleeding-rate of 12% which they found in their 
treated patients is " much superior" to the natural history 
of the condition. In a large cooperative study, to which 
the authors were themselves major contributors, the re-
bleeding rate in cases of aneurysms of the anterior part of 
the circle of Willis was 10% in the first week, 12% in the 
second, 7% in the third, and 8% in the fourth." These 
figures cannot be simply summated to obtain the re-bleeding 
rate over 2 or 3 weeks because the population of patients 
at risk is diminishing with time. The figure of 12% given 
in the trial of antifibrinolytic agents would seem to be an 
underestimate of the risk of re-bleeding, since some patients 
will have undergone surgical occlusion of their aneurysms 
or will have died. 
It is a matter of considerable importance to establish 
statistically whether antifibrinolytic therapy offers significant 
protection against re-bleeding from aneurysms. We and 
many other neurosurgeons would be immensely grateful 
to Mr Uttley and Mr Richardson if they could present 
firm evidence. 
University Department of Neurosurgery, 
Institute of Neurological Sciences, 
Glasgow G51 4TF. 
M. D. M. SHAW 
J. DOUGAS MILLER. 
1. Starz!, T. E., Chase, H. P., Putnam, C. \v/'1 Porter, Ie A. Lancet, 
1973, ii. <140 . 
,., Starzi, T. E., Chase, H. P., mutnam~ C. W., }.fora, J. J. ibid. Sept. 21, 
1974. ,J. 715 . 
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